Epilepsy in pregnancy
Epilepsy · Obstetric
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Pregnancy in women with epilepsy requires balancing seizure control against teratogenic risk of antiepileptic drugs. Preconception optimisation, high-dose folic acid and avoidance of sodium valproate are central.
Red flags
- Status epilepticus
- New-onset seizures in the second half of pregnancy (consider eclampsia)
- Deteriorating seizure control
- Poor medication adherence
- Signs of drug toxicity
Assessment
Differential diagnosis
- Known epilepsy on treatment
- Eclampsia (new seizures in late pregnancy)
- Gestational exacerbation of seizures
- Non-epileptic attack disorder
- Other causes of seizures (infection, hypoglycaemia)
Investigations
- Review seizure type, frequency and current medication
- Antiepileptic drug levels where clinically indicated (e.g. lamotrigine)
- Detailed anomaly scan and fetal cardiac assessment
- BP and urinalysis to distinguish from eclampsia if late seizures
- Fetal growth monitoring
Management
- Provide preconception counselling and optimise to monotherapy at the lowest effective dose
- Prescribe folic acid 5 mg daily before conception and through the first trimester
- Avoid sodium valproate in women of childbearing potential unless no alternative and within a pregnancy prevention programme
- Prefer lamotrigine or levetiracetam where seizure type permits
- Do not stop antiepileptic drugs abruptly because of seizure and status risk
- Monitor drug levels and adjust dose for levels that fall in pregnancy (notably lamotrigine)
- Offer vitamin K to the neonate and counsel on safe infant care (avoid co-sleeping, safe bathing)
- Plan birth in an obstetric unit with a seizure management plan
- Review medication and doses postnatally as levels change, and support breastfeeding which is generally safe
Drugs & doses
Folic acid 5 mg PO once daily preconception and first trimester
Lamotrigine or levetiracetam as preferred antiepileptics, dose titrated to levels
Avoid sodium valproate in those able to become pregnant
Lorazepam 4 mg IV or buccal midazolam 10 mg for acute seizures in labour
Disposition
Joint neurology and obstetric (maternal medicine) care; deliver in an obstetric unit with a documented seizure plan; emergency treatment for status epilepticus.
Complications & pitfalls
- Congenital malformations (highest with valproate)
- Neurodevelopmental impairment
- Sudden unexpected death in epilepsy
- Seizure-related maternal and fetal injury
- Status epilepticus
Exam pearls
- Most women with epilepsy have uncomplicated pregnancies on appropriate treatment
- Never stop antiepileptics abruptly to avoid harm
- Lamotrigine levels fall substantially in pregnancy and often need upward adjustment
- Valproate carries a roughly 10% malformation and 30-40% neurodevelopmental risk and must be avoided where possible
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.